2667-3681

Obesity Pillars

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 282 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact282 DOIs
2

Attach ORCID iDs across 37 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact37 DOIs
3

Deposit reference lists for 25 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact25 DOIs

DOIs for this ISSN

Showing the top 5 of 282 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Nutrition and physical activity: An Obesity Medicine Associa… (10.1016/j.obpill.2021.100005)
Abstract ORCID
82.66 44
2 Comparative efficacy and safety of GLP-1 receptor agonists f… (10.1016/j.obpill.2025.100162)
Abstract ORCID
71.57 26
3 Beyond BMI: Exploring obesity trends in the south Asian regi… (10.1016/j.obpill.2024.100156)
Abstract ORCID
65.05 19
4 Nutritional and activity recommendations for the child with… (10.1016/j.obpill.2022.100012)
Abstract ORCID
58.80 14
5 Obesity definition, diagnosis, bias, standard operating proc… (10.1016/j.obpill.2021.100004)
Abstract
50.00 99
6 Glucagon-like Receptor-1 agonists for obesity: Weight loss o… (10.1016/j.obpill.2024.100127)
Abstract
50.00 99
7 Artificial intelligence and obesity management: An Obesity M… (10.1016/j.obpill.2023.100065)
Abstract
48.98 90
8 Successful treatment of binge eating disorder with the GLP-1… (10.1016/j.obpill.2023.100080)
Abstract
47.71 80
9 Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 r… (10.1016/j.obpill.2024.100121)
Abstract
47.71 80
10 Assessment, differential diagnosis, and initial clinical eva… (10.1016/j.obpill.2022.100010)
Abstract ORCID
45.15 7
11 Obesity, dyslipidemia, and cardiovascular disease: A joint e… (10.1016/j.obpill.2024.100108)
Abstract
44.27 58
12 Effect of GLP-1 agonists on weight loss in patients with pol… (10.1016/j.obpill.2022.100016)
Abstract ORCID
42.25 6
13 Cancer and Obesity: An Obesity Medicine Association (OMA) Cl… (10.1016/j.obpill.2022.100026)
Abstract
41.80 46
14 Obesity, diabetes mellitus, and cardiometabolic risk: An Obe… (10.1016/j.obpill.2023.100056)
Abstract
41.33 44
15 Obesity and malnutrition in children and adults: A clinical… (10.1016/j.obpill.2023.100087)
Abstract
40.84 42
16 Anti-Obesity Medications and Investigational Agents: An Obes… (10.1016/j.obpill.2022.100018)
Abstract
40.05 39
17 Nutritional deficiencies and muscle loss in adults with type… (10.1016/j.obpill.2025.100186)
Abstract
39.49 37
18 Weight-centric treatment of type 2 diabetes mellitus (10.1016/j.obpill.2022.100045)
Abstract
39.21 36
19 Metabolic dysfunction-associated steatotic liver disease (MA… (10.1016/j.obpill.2025.100164)
Abstract
39.21 36
20 Why does type 2 diabetes mellitus impair weight reduction in… (10.1016/j.obpill.2023.100076)
Abstract
37.96 32
21 Obesity history, physical exam, laboratory, body composition… (10.1016/j.obpill.2021.100007)
Abstract
37.28 30
22 Obesity and hypertension: Obesity medicine association (OMA)… (10.1016/j.obpill.2023.100083)
Abstract
36.93 29
23 Sleep-disordered breathing, sleep apnea, and other obesity-r… (10.1016/j.obpill.2022.100043)
Abstract
35.78 26
24 Erratum to “Dietary intake by patients taking GLP-1 and dual… (10.1016/j.obpill.2024.100136)
Abstract References ORCID
35.78 2
25 Association between anxiety and eating behaviors in patients… (10.1016/j.obpill.2022.100021)
Abstract
35.37 25
26 Thirty Obesity Myths, Misunderstandings, and/or Oversimplifi… (10.1016/j.obpill.2022.100034)
Abstract
35.37 25
27 Relationship of visceral adiposity index (VAI) and visceral… (10.1016/j.obpill.2024.100140)
Abstract ORCID
34.95 4
28 Duties, tasks, knowledge and skills of an obesity medicine p… (10.1016/j.obpill.2024.100147)
Abstract ORCID
34.95 4
29 Nutritional priorities to support GLP-1 therapy for obesity:… (10.1016/j.obpill.2025.100181)
Abstract
34.04 22
30 Bariatric surgery, gastrointestinal hormones, and the microb… (10.1016/j.obpill.2022.100015)
Abstract
33.06 20
31 Behavior, motivational interviewing, eating disorders, and o… (10.1016/j.obpill.2022.100014)
Abstract
32.53 19
32 Differentiating monogenic and syndromic obesities from polyg… (10.1016/j.obpill.2024.100110)
Abstract
32.53 19
33 Weight-centric treatment of depression and chronic pain (10.1016/j.obpill.2022.100025)
Abstract
31.97 18
34 Nonalcoholic fatty liver disease and obesity: An Obesity Med… (10.1016/j.obpill.2022.100027)
Abstract
31.97 18
35 Comprehensive care for patients with obesity: An Obesity Med… (10.1016/j.obpill.2023.100070)
Abstract
31.97 18
36 A review of the evidence on cardiovascular outcomes from obe… (10.1016/j.obpill.2023.100071)
Abstract
31.38 17
37 Obesity, thrombosis, venous disease, lymphatic disease, and… (10.1016/j.obpill.2023.100092)
Abstract
31.38 17
38 Obesity Medicine Association (OMA): Advocacy update (10.1016/j.obpill.2021.100003)
Abstract ORCID
30.10 3
39 Obesity pillars roundtable: Obesity and individuals from the… (10.1016/j.obpill.2022.100013)
Abstract ORCID
30.10 3
40 Clinical review: Guide to pharmacological management in pedi… (10.1016/j.obpill.2023.100066)
Abstract
30.10 15
41 Outcomes of concomitant antiobesity medication use with endo… (10.1016/j.obpill.2024.100112)
Abstract
30.10 15
42 Optimizing nutrition, diet, and lifestyle communication in G… (10.1016/j.obpill.2024.100143)
Abstract
30.10 15
43 Appropriate use of the fixed-dose, extended-release combinat… (10.1016/j.obpill.2025.100170)
Abstract ORCID
30.10 3
44 Concomitant medications, functional foods, and supplements:… (10.1016/j.obpill.2022.100017)
Abstract
29.40 14
45 Leveraging the construct of physical literacy to promote phy… (10.1016/j.obpill.2022.100054)
Abstract
29.40 14
46 Once-weekly semaglutide administered after laparoscopic slee… (10.1016/j.obpill.2023.100098)
Abstract
29.40 14
47 Weight stigma and bias: A guide for pediatric clinicians (10.1016/j.obpill.2023.100058)
Abstract
28.65 13
48 Obesity management in primary care: A joint clinical perspec… (10.1016/j.obpill.2025.100172)
Abstract
28.65 13
49 Obesity Pillars Roundtable: Body mass index and body composi… (10.1016/j.obpill.2022.100044)
Abstract
27.85 12
50 Medication-induced weight gain and advanced therapies for th… (10.1016/j.obpill.2022.100048)
Abstract
27.85 12